로딩 중…
지수 로딩 중…
PharmGen Science, Inc.
004720· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩2,910-3.00%
2026-06-19
Price Chart
PharmGen Science, Inc.-33.26%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 65.92B KRW |
| Revenue | 173.52B KRW |
| Net Income | -116.90B KRW |
| Total Assets | 199.06B KRW |
| Net Assets | 150.36B KRW |
| Employees | 254 |
| Value | |
| P/B | 0.44x |
| P/S | 0.38x |
| EV/EBITDA | 9.28x |
| FCF Yield | -6.60% |
| Profitability | |
| ROE | -77.75% |
| ROA | -58.73% |
| Op. Margin | 3.29% |
| Revenue Growth | 1.04% |
| Earnings Growth | -3248.14% |
| Financial Health | |
| Debt Ratio | 32.38% |
| Total Debt | 5.50B KRW |
| FCF | -4.35B KRW |
| Cash | 18.41B KRW |
| Current Ratio | 2.90x |
| Net Debt/EBITDA | -2.26x |
| Performance | |
| 1Y Return | -33.26% |
| 1M Return | -18.60% |
| From 52W High | -46.99% |
| 1Y MDD | -40.91% |
| Trading | |
| Volume | 79,878 shares |
| Foreign Own. | 2.63% |
| Per Share | |
| EPS | -5,961 KRW |
| BPS | 6,862 KRW |
Company Info
Established in 1966 as Sudo Pharmaceutical Industry, this company engages in digestive system therapeutics and health functional foods. With headquarters and production facilities in Hwaseong, Gyeonggi-do, it operates wholesale and national branches, a global R&D center, and a development division, focusing on selling professional and general pharmaceuticals and new drug development. In 2021, it established a biosimilar new drug division and recruited experts, and in 2022, announced its R&D Vision 2030, aiming to become a specialized company in digestive system new drug development.